A large number of orthopaedic surgeons will go to market

Orthopedic Supplies Change Bureau! Some product prices drop 70%
Recently, according to the report of Cypress Blue, the Public Resource Trading Center of Jilin Province issued a notice to decide on the online sunshine procurement work for high-value orthopaedic consumables in the province and extend the acceptance of enterprise Quoting time for questioning materials. The background of the announcement was that in January of this year, Jilin province started the hanging of seven kinds of consumables such as orthopaedics.
Before the province, many provinces in the country had completed centralized provincial procurement of orthopaedics and consumables/online sunlight procurement. In the high-value consumables collection and procurement work that has been completed in various provinces, in the category of consumables, from practice, Orthopedic consumables are absolute price cuts, and the price cuts have been the most fierce. There are also many products that are directly linked to the purchase price. Some products can even reach 70%, 80% or more.
In fact, the new round of abolition of the reform of 'aid medicine' has been very clear at the end of 2017 – according to the “Opinions on Comprehensively Deepening the Reform of the Price Mechanism” of the National Development and Reform Commission on November 10, 2017, which explicitly states: Consolidation and cancellation drug Addition results, further cancel the medical supplies bonus.
It is learnt that after the document was issued, a number of high-value medical consumables cost and price surveys were conducted across the country to accurately grasp the high-value medical consumables price and cost situation. A normal-valued monitoring mechanism for high-value medical consumables was established to dynamically monitor the ex-factory value of high-value medical consumables. The port price, as well as the retail price in our country, origin and neighboring country (region), and publish it to the society in an appropriate way to give full play to the role of social supervision. Study to include some high-value medical consumables with comparable quality levels and similar price levels Medical service projects, indirectly controlling the price level of medical consumables through the establishment of medical service charging standards.
Don't look at the medical consumables plus only 5% to 10%, and there is no 15% increase in the drug, but once the consumables are cancelled, not only the public hospital The impact will be huge and the impact on the doctor will be very big. The day may be very sad.
The orthopedic field becomes a disaster-stricken area!
In fact, in recent years, the medical anti-corruption efforts in the orthopedic field have become more and more intensified. Orthopedic surgeons and directors have also become one of the most frequent news in the medical community.
In 2014, the Prosecution Authority of Shangqiu, Henan Province launched medical instruments In the field of purchase and sale of special investigations, a total of 30 people were placed on 59 cases. The Procuratorate reported that of the 59 people investigated and dealt with, 11 were medical device distributors, and the remaining 48 were doctors with prescribing rights in the orthopedic department of the hospital. Among them, orthopedic directors were 9 People, 7 deputy directors. 48 doctors involved in the city's 9 hospitals, including 6 hospitals all orthopedic doctors involved in receiving bribery.
In June 2016, the Procuratorate of Yangzhou City, Jiangsu Province issued a series of announcements, Director of the Department of Orthopaedics at First People’s Hospital of Yangzhou, Wang Mouguang, Deputy Director of Orthopedics, Fu You, Deputy Director of Orthopaedics, and Wang Jie, Director of Orthopedics, Wujin Hospital, Changzhou People’s Hospital. Cao, director of Orthopaedics Department of Gaoyou City Hospital, director of Bone Department of Baoying County People's Hospital, Ji Mouliang, was arrested on suspicion of bribery.
In July 2017, according to the judgment of the People's Court of Tanghe County, Henan Province, the court found that: Meng Mou, director of an orthopaedics department of Tanghe County Hospital, used it from February 2013 to April 2016. For the hospital's right to use orthopedic consumables company and the right to use orthopaedic consumables during the surgery, the company has long used a certain brand of consumables, and has received the salesperson Zhao Zhao, who has sold the brand consumables 37 times. Wang sent a total of 459,000 yuan in cash for the benefit of the above-mentioned company.
In November 2017, according to the court judgment of the Heilongjiang Yingchun Forest District Court, the court found that Pengmou, vice president and director of orthopaedics at the People's Hospital of Mishan City, used his position in late 2012 and late 2013 to use a certain business in Shanghai. Co., Ltd., Harbin Medical Equipment Co., Ltd. orthopaedic supplies, in its office received medical equipment supplier Wang Mou money twice, a total of 100000 yuan......
It can be said that corruption cases in the orthopedic field are very easy to form 'fail cases', and the issue of retrieving deduction and collecting red packets in the field of orthopaedic supplies has become one of the major breakthroughs in the field of anti-corruption in the medical field.
Force doctors to go to the market within the system
The cancellation of bonuses for orthopaedic supplies, and the increase in anti-corruption treatment in orthopaedic fields, will influence the orthopaedic specialists? A private orthopedic specialist chain leader told the medical community that former orthopedic specialists in the top three hospitals are seldom willing to join Private hospitals, but if consumables are cancelled, a large number of orthopaedic surgeons will take the initiative to go to the market. This will be a high probability event. It will be a great advantage for private hospitals.
In the view of one person in the industry, there is no doubt that the main force of medical reform is the group of doctors. Only the doctors can give full play to their subjective initiative, and medical reform can be successful. At present, on the one hand, under the pressure of public hospital reform and medical anti-corruption storms, it will A large number of doctors have pushed the market; On the other hand, the continuous opening up of the medical market, the rapid development of social medical services, and the attractiveness of the market for doctors have been greatly strengthened. Under the dual effects of thrust and attraction, there will inevitably be a large number of doctors Market, Can be part-time, full-time, can also be partnership or autonomy Entrepreneurship , Doctor Group, Clinic Hospital, etc.
He also said, 'The entry of these doctors will make the medical market active and expand, and will expand the social value, commercial value of these doctors, and create a win-win situation for patients, doctors, governments, and society.'
According to an orthopedic expert who went to the market to form a doctor group to “see the medical sector”, taking an outpatient clinic for an example, although his outpatient 'registration fee' is 15 times that of the public hospital, the overall treatment of specific diseases The cost is lower than in public hospitals.
'We have saved a lot of unnecessary consumables, and we have chosen the right consumables, not expensive ones. ' According to the experts, the patients with the above-mentioned diseases need to take several gypsums during the treatment process, according to him for a long time. The clinical experience, if the doctor can strictly implement the quality control, even if the use of cheaper gypsum material, can still achieve a very satisfactory therapeutic effect.
"On the other hand, once the doctor's work has achieved its own value in the market, it will in turn force public hospital reforms, further respect the doctor's labor value, and increase the sunshine income of doctors in public hospitals. 'The industry insiders said.
2016 GoodChinaBrand | ICP: 12011751 | China Exports